secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001193125-24-018748
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q4 revenue up 11.6% to $17.3B; FY2024 EPS guidance $19.70-$21.20; CFO succession announced
--------------------------------------------------------------------------------

- Q4 2023 revenue $17.303B (+11.6% YoY); net income $1.607B ($5.93 diluted EPS) vs $2.081B ($7.28) in Q4 2022, which included $1.326B gain.
- Adjusted EBITDA $3.618B (up from $3.179B); same facility admissions +3.1%, equivalent admissions +3.9%.
- FY2024 guidance: revenue $67.75-$70.25B, Adjusted EBITDA $12.85-$13.55B, diluted EPS $19.70-$21.20; capex $5.1-$5.3B.
- Board authorized additional $6B share repurchase program; quarterly dividend declared at $0.66 per share (unchanged).
- CFO Bill Rutherford retiring May 1, 2024; succeeded by Mike Marks, current SVP Finance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/d734797d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-018748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer